Kawai; Stephen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kawai; Stephen.The latest application filed is for "inhibitors of human immunodeficiency virus replication".

Company Profile

0.14.15

Kawai; Stephen - Laval CA
Kawai; Stephen - Montreal N/A CA
Kawai; Stephen - Cote St-Luc CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inhibitors Of Human Immunodeficiency Virus Replication App 20140296228 - Tsantrizos; Youla S. ; et al.	2014-10-02
Inhibitors of human immunodeficiency virus replication Grant 8,841,331 - Yoakim , et al. September 23, 2	2014-09-23
Inhibitors of human immunodeficiency virus replication Grant 8,710,230 - Tsantrizos , et al. April 29, 2	2014-04-29
Inhibitors Of Human Immunodeficiency Virus Replication App 20130203747 - Yoakim; Christiane ; et al.	2013-08-08
Inhibitors Of Human Immunodeficiency Virus Replication App 20130197231 - Tsantrizos; Youla S. ; et al.	2013-08-01
Inhibitors Of Human Immunodeficiency Virus Replication App 20130190491 - Tsantrizos; Youla S. ; et al.	2013-07-25
Derivatives of 1-Phenyl-1,5-Dihydro-Benzo[B] [1,4]Diazepine-2,4-Dione as Inhibitors of HIV Replication App 20130150350 - Simoneau; Bruno ; et al.	2013-06-13
Inhibitors of human immunodeficiency virus replication Grant 8,461,180 - Tsantrizos , et al. June 11, 2	2013-06-11
Inhibitors of human immunodeficiency virus replication Grant 8,377,960 - Tsantrizos , et al. February 19, 2	2013-02-19
Inhibitors of human immunodeficiency virus replication Grant 8,354,429 - Tsantrizos , et al. January 15, 2	2013-01-15
Inhibitors of human immunodeficiency virus replication Grant 8,338,441 - Yoakim , et al. December 25, 2	2012-12-25
Inhibitors of human immunodeficiency virus replication Grant 7,956,068 - Carson , et al. June 7, 2	2011-06-07
Inhibitors Of Human Immunodeficiency Virus Replication App 20110118249 - Tsantrizos; Youla S. ; et al.	2011-05-19
Viral polymerase inhibitors Grant 7,888,363 - Beaulieu , et al. February 15, 2	2011-02-15
Inhibitors Of Human Immunodeficiency Virus Replication App 20110028464 - Tsantrizos; Youla S. ; et al.	2011-02-03
Inhibitors Of Human Immunodeficiency Virus Replication App 20100311735 - Tsantrizos; Youla S. ; et al.	2010-12-09
Inhibitors Of Human Immunodeficiency Virus Replication App 20100305115 - Carson; Rebekah J. ; et al.	2010-12-02
Inhibitors Of Human Immunodeficiency Virus Replication App 20100292227 - YOAKIM; CHRISTIANE ; et al.	2010-11-18
Viral Polymerase Inhibitors App 20070249629 - BEAULIEU; Pierre ; et al.	2007-10-25
Viral polymerase inhibitors Grant 7,241,801 - Beaulieu , et al. July 10, 2	2007-07-10
Viral Polymerase Inhibitors App 20070142380 - Beaulieu; Pierre Louis ; et al.	2007-06-21
Viral polymerase inhibitors Grant 7,223,785 - Beaulieu , et al. May 29, 2	2007-05-29
Viral polymerase inhibitors App 20060052418 - Beaulieu; Pierre ; et al.	2006-03-09
Viral polymerase inhibitors App 20040171626 - Beaulieu, Pierre Louis ; et al.	2004-09-02
Azetidinone derivatives for the treatment of HCMV infections Grant 6,211,170 - Yoakim , et al. April 3, 2	2001-04-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.